MedTrace Logo

Optimizing Walking Function of Stroke Survivors by a Task-Oriented Home Exercise Program

NCT02779036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2017-06-08

No results posted yet for this study

Summary

In a randomized-controlled study, the effects of a structured, progressive, task-oriented home exercise program to optimize walking competency will be evaluated in subacute stroke survivors.

Conditions

Interventions

PROCEDURE

Task-oriented home exercise

Structured, walking related task-oriented home exercise program with three progressive steps, at moderate to high intensity, 60 minutes per session, three sessions per week for total 8 weeks.

PROCEDURE

Usual Physiotherapy Care

Deficits-oriented free active and resisted lower extremity exercises with bicycling and overground walking , 60 minutes per session, three sessions per week for total 8 weeks.

Sponsors & Collaborators

  • University of Medical Technology, Yangon

    collaborator OTHER

  • National Rehabilitation Hospital, Myanmar

    collaborator UNKNOWN

  • Yangon General Hospital, Myanmar

    collaborator UNKNOWN

  • Mahidol University

    lead OTHER

Principal Investigators

  • Thin Thin Moe, M.Med.Tech · Mahidol University

  • Chutima Jalayondeja, Dr.P.H. MSc · Mahidol University

  • Sopa Pichaiyongwongdee, M.Sc. B.Sc · Mahidol University

  • Vimonwan Hiengkaew, PhD. MSc · Mahidol University

  • Jarugool Tretriluxana, PhD. MSc · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • Burma

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02779036 on ClinicalTrials.gov